Laddar...
Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with a 5-year mortality rate of ~50%. The development of immunotherapies has improved the survival of patients with HNSCC, but, the long-term prognosis of patients with recurrent or metastatic HNSCC remains poor. HNSCC...
Sparad:
| I publikationen: | Front Oncol |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6803444/ https://ncbi.nlm.nih.gov/pubmed/31681613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01084 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|